The Asia Pacific Hysterectomy Device Market would witness market growth of 6.5% CAGR during the forecast period (2022-2028).
The uterus is removed in vasectomy hysterectomy by incision at the top of the vagina. There is no visible external incision. In the vagina, dissolvable sutures are inserted. Uterine prolapse and other benign (or noncancerous) diseases are typical applications. This is the best option since it has the shortest recovery period (up to four weeks) and the fewest problems. Patients frequently return home on the same day as surgery.
During a laparoscopic procedure, a laparoscope (a thin tube with a video camera at the end) is introduced into the lower abdomen through a small incision in the belly button. Then, many further microscopic incisions are made to install surgical devices. Using abdominal or vaginal incisions, the uterus can be removed in small parts. Some patients are discharged from the hospital on the same day or the very next morning. Recovery after an abdominal hysterectomy is quicker and less painful.
In Australia, 67 percent of adults were overweight or obese in 2017–18 (36% were overweight but not obese, and 31% were obese). About 12.5 million adult people. Obesity is more common in older age groups. Only 16% of people between 18 and 24 were obese, but 41% of people between 65 and 74 were obese. 46% of women had a waist size strongly linked to a higher risk of chronic disease. This risk also increased with age, reaching a peak of 65% for women aged 75 to 84. So, the rise in obesity in the region will increase the cases of fibroids or other illnesses and surge the need for hysterectomy. This will help the hysterectomy device market grow in the Asia-Pacific region.
The China market dominated the Asia Pacific Hysterectomy Device Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $35.3 million by 2028. The Japan market is experiencing a CAGR of 5.8% during (2022 - 2028). Additionally, The India market would display a CAGR of 7.1% during (2022 - 2028).
Based on Disease Type, the market is segmented into Chronic Pelvic Pain, Fibroids, Uterine Cancer and Others. Based on End User, the market is segmented into Hospitals, Ambulatory Surgical Centers and Others. Based on Surgical Approach, the market is segmented into Abdominal Hysterectomy, Laparoscopic Hysterectomy, Robotic-assisted Laparoscopic Hysterectomy and Vaginal Hysterectomy. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: The Worldwide Hysterectomy Device Market is Projected to reach USD 450.5 Million by 2028, at a CAGR of 5.5%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, B. Braun Melsungen AG, ConMed Corporation, Johnson & Johnson, Richard Wolf GmbH, Karl Storz SE & Co. KG, The Cooper Companies, Inc., Laborie Medical Technologies (Patricia Industries) (Investor AB), Fortimedix Surgical B.V., and Conkin Surgical Instruments Ltd.
By Disease Type
By End User
By Surgical Approach
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
